 |
Recombinant bactericidal/permeability-increasing protein |
|---|---|
| Trade Name | Neuprex |
| Orphan Indication | Severe meningococcal disease |
| USA Market Approval | USA |
| USA Designation Date | 1998-06-22 00:00:00 |
| Sponsor | Xoma (US) LLC;2910 Seventh Street;Berkeley, California, 94710 |
